HEADER AGGREGATION INHIBITOR, GP ANTAGONIST 04-SEP-91 1KST OBSLTE 28-JAN-03 1KST 1N4Y TITLE SOLUTION STRUCTURE OF KISTRIN, A POTENT PLATELET TITLE 2 AGGREGATION INHIBITOR AND GP IIB-IIIA ANTAGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: KISTRIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS AGGREGATION INHIBITOR, GP ANTAGONIST EXPDTA NMR, 8 STRUCTURES AUTHOR M.ADLER,R.A.LAZARUS,M.S.DENNIS,G.WAGNER REVDAT 1 31-JAN-94 1KST 0 JRNL AUTH M.ADLER,R.A.LAZARUS,M.S.DENNIS,G.WAGNER JRNL TITL SOLUTION STRUCTURE OF KISTRIN, A POTENT PLATELET JRNL TITL 2 AGGREGATION INHIBITOR AND GP IIB-IIIA ANTAGONIST JRNL REF SCIENCE V. 253 445 1991 JRNL REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1KST COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 HYDROGEN ATOMS IN THIS ENTRY HAVE BEEN ASSIGNED NAMES REMARK 5 CONSISTENT WITH THE RECOMMENDATIONS OF THE IUPAC-IUB REMARK 5 COMMISSION ON BIOCHEMICAL NOMENCLATURE (SEE,E.G., J.MOL. REMARK 5 BIOL. 52, 1 (1970)). THE PROTEIN DATA BANK HAS FOLLOWED REMARK 5 RULE 4.4 OF THE RECOMMENDATIONS WITH THE FOLLOWING REMARK 5 MODIFICATION: WHEN MORE THAN ONE HYDROGEN ATOM IS BONDED TO REMARK 5 A SINGLE NON-HYDROGEN ATOM, THE HYDROGEN ATOM NUMBER REMARK 5 DESIGNATION IS GIVEN AS THE FIRST CHARACTER OF THE ATOM REMARK 5 NAME RATHER THAN AS THE LAST CHARACTER (E.G. H*BETA*1 IS REMARK 5 DENOTED AS 1HB ). REMARK 6 REMARK 6 SOME MINOR CHANGES HAVE BEEN MADE TO NOE CONSTRAINT FILE REMARK 6 SINCE PUBLICATION OF THE JRNL ARTICLE ABOVE, BUT LITTLE REMARK 6 ELSE HAS CHANGED. THE DETAILS CONCERNING THE STRUCTURE REMARK 6 CALCULATIONS MAY BE FOUND IN THE JRNL ARTICLE. REMARK 7 REMARK 7 THE PLANARITY OF PEPTIDE BONDS IS NOT PRESERVED BY DSPACE, REMARK 7 WITH THE OMEGA ANGLE FOR SOME RESIDUES VARYING BY AS MUCH REMARK 7 AS 40 DEGREES FROM THE IDEAL. REMARK 8 REMARK 8 THE DEPOSITORS HAVE NOT CHECKED THE STEREOCHEMISTRY OF THE REMARK 8 AMINO ACIDS AND THERE HAVE BEEN SOME INFORMAL DISCUSSIONS REMARK 8 THAT THE CHIRALITY OF THE BETA CARBONS MAY BE INVERTED BY REMARK 8 SOME VERSIONS OF DSPACE. REMARK 9 REMARK 9 PROTEIN DATA BANK ADVISORY NOTICE: REMARK 9 THE 8 MODELS PRESENTED IN THIS ENTRY DO NOT HAVE A COMMON REMARK 9 ORIENTATION. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : NULL REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 1 PRO A 9 CB - CA - C ANGL. DEV. = 20.1 DEGREES REMARK 500 1 PRO A 12 CB - CA - C ANGL. DEV. = 18.0 DEGREES REMARK 500 1 PRO A 23 CB - CA - C ANGL. DEV. = 21.9 DEGREES REMARK 500 1 PRO A 48 CB - CA - C ANGL. DEV. = 20.6 DEGREES REMARK 500 1 PRO A 53 CB - CA - C ANGL. DEV. = 21.4 DEGREES REMARK 500 1 PRO A 65 CB - CA - C ANGL. DEV. = 18.9 DEGREES REMARK 500 2 PRO A 9 CB - CA - C ANGL. DEV. = 20.8 DEGREES REMARK 500 2 PRO A 23 CB - CA - C ANGL. DEV. = 20.0 DEGREES REMARK 500 2 PRO A 48 CB - CA - C ANGL. DEV. = 21.4 DEGREES REMARK 500 2 PRO A 53 CB - CA - C ANGL. DEV. = 21.2 DEGREES REMARK 500 2 PRO A 65 CB - CA - C ANGL. DEV. = 19.9 DEGREES REMARK 500 3 PRO A 9 CB - CA - C ANGL. DEV. = 21.1 DEGREES REMARK 500 3 PRO A 12 CB - CA - C ANGL. DEV. = 19.9 DEGREES REMARK 500 3 PRO A 23 CB - CA - C ANGL. DEV. = 20.9 DEGREES REMARK 500 3 PRO A 48 CB - CA - C ANGL. DEV. = 20.3 DEGREES REMARK 500 3 PRO A 53 CB - CA - C ANGL. DEV. = 20.8 DEGREES REMARK 500 3 PRO A 65 CB - CA - C ANGL. DEV. = 21.0 DEGREES REMARK 500 4 PRO A 9 CB - CA - C ANGL. DEV. = 21.6 DEGREES REMARK 500 4 PRO A 12 CB - CA - C ANGL. DEV. = 20.3 DEGREES REMARK 500 4 PRO A 23 CB - CA - C ANGL. DEV. = 17.6 DEGREES REMARK 500 4 PRO A 48 CB - CA - C ANGL. DEV. = 17.8 DEGREES REMARK 500 4 PRO A 53 CB - CA - C ANGL. DEV. = 21.7 DEGREES REMARK 500 4 PRO A 65 CB - CA - C ANGL. DEV. = 20.9 DEGREES REMARK 500 5 PRO A 9 CB - CA - C ANGL. DEV. = 21.2 DEGREES REMARK 500 5 PRO A 23 CB - CA - C ANGL. DEV. = 20.7 DEGREES REMARK 500 5 PRO A 48 CB - CA - C ANGL. DEV. = 17.7 DEGREES REMARK 500 5 PRO A 53 CB - CA - C ANGL. DEV. = 21.2 DEGREES REMARK 500 5 PRO A 65 CB - CA - C ANGL. DEV. = 20.9 DEGREES REMARK 500 6 PRO A 9 CB - CA - C ANGL. DEV. = 21.6 DEGREES REMARK 500 6 PRO A 12 CB - CA - C ANGL. DEV. = 19.6 DEGREES REMARK 500 6 PRO A 23 CB - CA - C ANGL. DEV. = 21.3 DEGREES REMARK 500 6 PRO A 48 CB - CA - C ANGL. DEV. = 20.7 DEGREES REMARK 500 6 PRO A 53 CB - CA - C ANGL. DEV. = 21.4 DEGREES REMARK 500 6 PRO A 65 CB - CA - C ANGL. DEV. = 22.0 DEGREES REMARK 500 7 PRO A 9 CB - CA - C ANGL. DEV. = 20.8 DEGREES REMARK 500 7 PRO A 23 CB - CA - C ANGL. DEV. = 19.3 DEGREES REMARK 500 7 PRO A 48 CB - CA - C ANGL. DEV. = 20.7 DEGREES REMARK 500 7 PRO A 53 CB - CA - C ANGL. DEV. = 20.1 DEGREES REMARK 500 7 PRO A 65 CB - CA - C ANGL. DEV. = 20.0 DEGREES REMARK 500 8 PRO A 9 CB - CA - C ANGL. DEV. = 20.1 DEGREES REMARK 500 8 PRO A 12 CB - CA - C ANGL. DEV. = 18.3 DEGREES REMARK 500 8 PRO A 23 CB - CA - C ANGL. DEV. = 18.5 DEGREES REMARK 500 8 PRO A 48 CB - CA - C ANGL. DEV. = 20.6 DEGREES REMARK 500 8 PRO A 53 CB - CA - C ANGL. DEV. = 19.1 DEGREES REMARK 500 8 PRO A 65 CB - CA - C ANGL. DEV. = 19.4 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 4 -169.92 91.07 REMARK 500 1 GLN A 60 -113.77 -154.00 REMARK 500 3 ASP A 54 142.88 65.32 REMARK 500 3 TYR A 67 -52.95 86.29 REMARK 500 6 ARG A 49 -87.29 74.09 REMARK 500 8 ARG A 46 121.75 64.00 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS A 4 ASP A 5 1 -147.10 REMARK 500 ASN A 11 PRO A 12 1 -144.20 REMARK 500 CYS A 13 CYS A 14 1 -140.60 REMARK 500 CYS A 36 LYS A 37 1 146.08 REMARK 500 PHE A 38 SER A 39 1 -148.82 REMARK 500 ASN A 11 PRO A 12 2 -149.02 REMARK 500 CYS A 13 CYS A 14 2 -139.95 REMARK 500 GLY A 30 LEU A 31 2 145.29 REMARK 500 CYS A 32 CYS A 33 2 -142.29 REMARK 500 PHE A 38 SER A 39 2 -146.89 REMARK 500 ARG A 49 GLY A 50 2 147.58 REMARK 500 PRO A 53 ASP A 54 2 145.54 REMARK 500 CYS A 57 THR A 58 2 143.24 REMARK 500 GLN A 60 SER A 61 2 -147.82 REMARK 500 ASN A 11 PRO A 12 3 -143.63 REMARK 500 CYS A 14 ASP A 15 3 142.85 REMARK 500 GLY A 30 LEU A 31 3 -147.00 REMARK 500 LEU A 31 CYS A 32 3 144.14 REMARK 500 GLU A 34 GLN A 35 3 -148.77 REMARK 500 GLN A 35 CYS A 36 3 141.61 REMARK 500 SER A 39 ARG A 40 3 142.87 REMARK 500 GLY A 42 LYS A 43 3 149.83 REMARK 500 ASN A 11 PRO A 12 4 -139.88 REMARK 500 LEU A 21 ARG A 22 4 -146.37 REMARK 500 GLY A 30 LEU A 31 4 -146.45 REMARK 500 LEU A 31 CYS A 32 4 133.05 REMARK 500 CYS A 36 LYS A 37 4 143.40 REMARK 500 ARG A 46 ILE A 47 4 -146.90 REMARK 500 PRO A 48 ARG A 49 4 -147.56 REMARK 500 CYS A 57 THR A 58 4 138.18 REMARK 500 CYS A 13 CYS A 14 5 -148.74 REMARK 500 CYS A 36 LYS A 37 5 148.77 REMARK 500 PHE A 38 SER A 39 5 -143.99 REMARK 500 ILE A 44 CYS A 45 5 141.26 REMARK 500 ASN A 11 PRO A 12 6 -148.74 REMARK 500 ARG A 22 PRO A 23 6 -148.17 REMARK 500 CYS A 32 CYS A 33 6 149.77 REMARK 500 GLN A 35 CYS A 36 6 143.43 REMARK 500 CYS A 36 LYS A 37 6 148.55 REMARK 500 PHE A 38 SER A 39 6 136.69 REMARK 500 CYS A 45 ARG A 46 6 -141.35 REMARK 500 CYS A 57 THR A 58 6 133.29 REMARK 500 THR A 58 GLY A 59 6 147.35 REMARK 500 ASN A 11 PRO A 12 7 -136.75 REMARK 500 GLY A 30 LEU A 31 7 -136.19 REMARK 500 LEU A 31 CYS A 32 7 138.41 REMARK 500 GLN A 35 CYS A 36 7 146.48 REMARK 500 CYS A 45 ARG A 46 7 -143.38 REMARK 500 PRO A 9 GLU A 10 8 -149.24 REMARK 500 ASN A 11 PRO A 12 8 -137.62 REMARK 500 PRO A 12 CYS A 13 8 144.14 REMARK 500 CYS A 13 CYS A 14 8 -148.29 REMARK 500 PRO A 23 GLY A 24 8 -146.66 REMARK 500 GLU A 29 GLY A 30 8 149.72 REMARK 500 LEU A 31 CYS A 32 8 148.04 REMARK 500 GLY A 42 LYS A 43 8 145.68 REMARK 500 PRO A 53 ASP A 54 8 -148.92 REMARK 500 ASP A 55 ARG A 56 8 -143.64 REMARK 500 CYS A 57 THR A 58 8 142.15 REMARK 500 GLN A 60 SER A 61 8 -140.46 DBREF 1KST A 1 68 UNP P17494 DISI_AGKRH 1 68 SEQRES 1 A 68 GLY LYS GLU CYS ASP CYS SER SER PRO GLU ASN PRO CYS SEQRES 2 A 68 CYS ASP ALA ALA THR CYS LYS LEU ARG PRO GLY ALA GLN SEQRES 3 A 68 CYS GLY GLU GLY LEU CYS CYS GLU GLN CYS LYS PHE SER SEQRES 4 A 68 ARG ALA GLY LYS ILE CYS ARG ILE PRO ARG GLY ASP MET SEQRES 5 A 68 PRO ASP ASP ARG CYS THR GLY GLN SER ALA ASP CYS PRO SEQRES 6 A 68 ARG TYR HIS FTNOTE 1 CYS 4 - ASP 5 MODEL 1 OMEGA =212.90 PEPTIDE BOND DEVIATES FTNOTE 1 SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 2 ASN 11 - PRO 12 MODEL 1 OMEGA =215.80 PEPTIDE BOND FTNOTE 2 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 3 CYS 13 - CYS 14 MODEL 1 OMEGA =219.40 PEPTIDE BOND FTNOTE 3 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 4 CYS 36 - LYS 37 MODEL 1 OMEGA =146.08 PEPTIDE BOND FTNOTE 4 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 5 PHE 38 - SER 39 MODEL 1 OMEGA =211.18 PEPTIDE BOND FTNOTE 5 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 6 ASN 11 - PRO 12 MODEL 2 OMEGA =210.98 PEPTIDE BOND FTNOTE 6 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 7 CYS 13 - CYS 14 MODEL 2 OMEGA =220.05 PEPTIDE BOND FTNOTE 7 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 8 GLY 30 - LEU 31 MODEL 2 OMEGA =145.29 PEPTIDE BOND FTNOTE 8 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 9 CYS 32 - CYS 33 MODEL 2 OMEGA =217.71 PEPTIDE BOND FTNOTE 9 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 10 PHE 38 - SER 39 MODEL 2 OMEGA =213.11 PEPTIDE BOND FTNOTE 10 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 11 ARG 49 - GLY 50 MODEL 2 OMEGA =147.58 PEPTIDE BOND FTNOTE 11 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 12 PRO 53 - ASP 54 MODEL 2 OMEGA =145.54 PEPTIDE BOND FTNOTE 12 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 13 CYS 57 - THR 58 MODEL 2 OMEGA =143.24 PEPTIDE BOND FTNOTE 13 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 14 GLN 60 - SER 61 MODEL 2 OMEGA =212.18 PEPTIDE BOND FTNOTE 14 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 15 ASN 11 - PRO 12 MODEL 3 OMEGA =216.37 PEPTIDE BOND FTNOTE 15 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 16 CYS 14 - ASP 15 MODEL 3 OMEGA =142.85 PEPTIDE BOND FTNOTE 16 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 17 GLY 30 - LEU 31 MODEL 3 OMEGA =213.00 PEPTIDE BOND FTNOTE 17 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 18 LEU 31 - CYS 32 MODEL 3 OMEGA =144.14 PEPTIDE BOND FTNOTE 18 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 19 GLU 34 - GLN 35 MODEL 3 OMEGA =211.23 PEPTIDE BOND FTNOTE 19 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 20 GLN 35 - CYS 36 MODEL 3 OMEGA =141.61 PEPTIDE BOND FTNOTE 20 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 21 SER 39 - ARG 40 MODEL 3 OMEGA =142.87 PEPTIDE BOND FTNOTE 21 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 22 GLY 42 - LYS 43 MODEL 3 OMEGA =149.83 PEPTIDE BOND FTNOTE 22 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 23 ASN 11 - PRO 12 MODEL 4 OMEGA =220.11 PEPTIDE BOND FTNOTE 23 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 24 LEU 21 - ARG 22 MODEL 4 OMEGA =213.63 PEPTIDE BOND FTNOTE 24 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 25 GLY 30 - LEU 31 MODEL 4 OMEGA =213.55 PEPTIDE BOND FTNOTE 25 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 26 LEU 31 - CYS 32 MODEL 4 OMEGA =133.05 PEPTIDE BOND FTNOTE 26 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 27 CYS 36 - LYS 37 MODEL 4 OMEGA =143.40 PEPTIDE BOND FTNOTE 27 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 28 ARG 46 - ILE 47 MODEL 4 OMEGA =213.10 PEPTIDE BOND FTNOTE 28 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 29 PRO 48 - ARG 49 MODEL 4 OMEGA =212.44 PEPTIDE BOND FTNOTE 29 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 30 CYS 57 - THR 58 MODEL 4 OMEGA =138.19 PEPTIDE BOND FTNOTE 30 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 31 CYS 13 - CYS 14 MODEL 5 OMEGA =211.26 PEPTIDE BOND FTNOTE 31 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 32 CYS 36 - LYS 37 MODEL 5 OMEGA =148.78 PEPTIDE BOND FTNOTE 32 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 33 PHE 38 - SER 39 MODEL 5 OMEGA =216.01 PEPTIDE BOND FTNOTE 33 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 34 ILE 44 - CYS 45 MODEL 5 OMEGA =141.26 PEPTIDE BOND FTNOTE 34 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 35 ASN 11 - PRO 12 MODEL 6 OMEGA =211.26 PEPTIDE BOND FTNOTE 35 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 36 ARG 22 - PRO 23 MODEL 6 OMEGA =211.83 PEPTIDE BOND FTNOTE 36 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 37 CYS 32 - CYS 33 MODEL 6 OMEGA =149.77 PEPTIDE BOND FTNOTE 37 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 38 GLN 35 - CYS 36 MODEL 6 OMEGA =143.43 PEPTIDE BOND FTNOTE 38 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 39 CYS 36 - LYS 37 MODEL 6 OMEGA =148.55 PEPTIDE BOND FTNOTE 39 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 40 PHE 38 - SER 39 MODEL 6 OMEGA =136.69 PEPTIDE BOND FTNOTE 40 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 41 CYS 45 - ARG 46 MODEL 6 OMEGA =218.64 PEPTIDE BOND FTNOTE 41 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 42 CYS 57 - THR 58 MODEL 6 OMEGA =133.29 PEPTIDE BOND FTNOTE 42 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 43 THR 58 - GLY 59 MODEL 6 OMEGA =147.35 PEPTIDE BOND FTNOTE 43 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 44 ASN 11 - PRO 12 MODEL 7 OMEGA =223.25 PEPTIDE BOND FTNOTE 44 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 45 GLY 30 - LEU 31 MODEL 7 OMEGA =223.81 PEPTIDE BOND FTNOTE 45 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 46 LEU 31 - CYS 32 MODEL 7 OMEGA =138.41 PEPTIDE BOND FTNOTE 46 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 47 GLN 35 - CYS 36 MODEL 7 OMEGA =146.48 PEPTIDE BOND FTNOTE 47 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 48 CYS 45 - ARG 46 MODEL 7 OMEGA =216.62 PEPTIDE BOND FTNOTE 48 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 49 PRO 9 - GLU 10 MODEL 8 OMEGA =210.76 PEPTIDE BOND DEVIATES FTNOTE 49 SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 50 ASN 11 - PRO 12 MODEL 8 OMEGA =222.38 PEPTIDE BOND FTNOTE 50 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 51 PRO 12 - CYS 13 MODEL 8 OMEGA =144.14 PEPTIDE BOND FTNOTE 51 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 52 CYS 13 - CYS 14 MODEL 8 OMEGA =211.71 PEPTIDE BOND FTNOTE 52 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 53 PRO 23 - GLY 24 MODEL 8 OMEGA =213.34 PEPTIDE BOND FTNOTE 53 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 54 GLU 29 - GLY 30 MODEL 8 OMEGA =149.72 PEPTIDE BOND FTNOTE 54 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 55 LEU 31 - CYS 32 MODEL 8 OMEGA =148.04 PEPTIDE BOND FTNOTE 55 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 56 GLY 42 - LYS 43 MODEL 8 OMEGA =145.68 PEPTIDE BOND FTNOTE 56 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 57 PRO 53 - ASP 54 MODEL 8 OMEGA =211.08 PEPTIDE BOND FTNOTE 57 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 58 ASP 55 - ARG 56 MODEL 8 OMEGA =216.36 PEPTIDE BOND FTNOTE 58 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 59 CYS 57 - THR 58 MODEL 8 OMEGA =142.16 PEPTIDE BOND FTNOTE 59 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 60 GLN 60 - SER 61 MODEL 8 OMEGA =219.54 PEPTIDE BOND FTNOTE 60 DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION SHEET 1 A 2 ILE A 44 ILE A 47 0 SHEET 2 A 2 MET A 52 ASP A 55 -1 O MET A 52 N ILE A 47 SSBOND 1 CYS A 4 CYS A 19 SSBOND 2 CYS A 6 CYS A 14 SSBOND 3 CYS A 13 CYS A 36 SSBOND 4 CYS A 27 CYS A 33 SSBOND 5 CYS A 32 CYS A 57 SSBOND 6 CYS A 45 CYS A 64 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL CONECT 52 229 CONECT 74 173 CONECT 163 462 CONECT 173 74 CONECT 229 52 CONECT 352 420 CONECT 410 796 CONECT 420 352 CONECT 462 163 CONECT 607 877 CONECT 796 410 CONECT 877 607 MASTER 217 60 0 0 2 0 0 6 7664 8 12 6 END